Clinical trial
Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer
NCT00003960 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other · Completed
Key facts
| NCT number | NCT00003960 |
|---|---|
| Title | Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer |
| Official title | Matched Unrelated and Haploidentical Bone Marrow Transplantation for Hematologic Malignancies |
| Lead sponsor | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes |
| Intervention type | Drug, Procedure |
| Interventions | busulfan, cyclophosphamide, methylprednisolone, allogeneic bone marrow transplantation, in vitro-treated bone marrow transplantation |
| Enrollment | 36 |
| Start date | Apr 1, 1998 |
| Primary completion | Sep 1, 2001 |
| Completion | Sep 1, 2001 |
| First posted | Apr 28, 2004 |
| Last update posted | May 2, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: